{"id":"sgx942","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site reactions"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by stimulating the proliferation and migration of fibroblasts and other cells involved in wound repair, promoting tissue regeneration and accelerating the healing process.","oneSentence":"SGX942 is a recombinant human platelet-derived growth factor isoform BB (PDGF-BB) used to promote wound healing.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:16.214Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of cutaneous squamous cell carcinoma (cSCC) and other cutaneous malignancies"}]},"trialDetails":[{"nctId":"NCT06386744","phase":"PHASE2","title":"Dusquetide for the Treatment of Behcet's Disease","status":"COMPLETED","sponsor":"Soligenix","startDate":"2024-11-18","conditions":"Behçet Disease","enrollment":8},{"nctId":"NCT03237325","phase":"PHASE3","title":"DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer","status":"COMPLETED","sponsor":"Soligenix","startDate":"2017-12-04","conditions":"Squamous Cell Carcinoma of the Oral Cavity and Oropharynx, Oral Mucositis","enrollment":266},{"nctId":"NCT02013050","phase":"PHASE2","title":"A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer","status":"COMPLETED","sponsor":"Soligenix","startDate":"2013-12","conditions":"Oral Mucositis","enrollment":111}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dusquetide"],"phase":"phase_3","status":"active","brandName":"SGX942","genericName":"SGX942","companyName":"Soligenix","companyId":"soligenix","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SGX942 is a recombinant human platelet-derived growth factor isoform BB (PDGF-BB) used to promote wound healing. Used for Treatment of cutaneous squamous cell carcinoma (cSCC) and other cutaneous malignancies.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}